Neutrophil myeloperoxidase regulates T-cell−driven tissue inflammation in mice by inhibiting dendritic cell function
Dragana Odobasic(Centre for Inflammation Research), Stephen R. Holdsworth(University of Auckland), Kristy L. Edgtton(Centre for Inflammation Research), Eric F. Morand(Novartis (Switzerland)), Kim M. O’Sullivan(Centre for Inflammation Research), A. Richard Kitching(Monash Health), Ruth Muljadi(Centre for Inflammation Research), Yuan Yang(Xihua University), Diana Shu Yee Tan(Centre for Inflammation Research), Shaun A. Summers(Monash Health)
Cited by 151
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726